Synthesis of bioreductive esters from fungal compounds

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 6, 2007, Pages 930-935

  Weerapreeyakul, Natthida ^a   Anorach, Rutchayaporn ^a   Khuansawad, Thidarut ^a   Yenjai, Chavi ^b   Isaka, Masahiko ^c  

^a KHON KAEN UNIVERSITY   (Thailand)

^b Khon Kaen University   (Thailand)

^c NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Bioreductive ester; Cytotoxic; Fungal compound; Phaseolinone; Phomenone; Preussomerin G; Preussomerin I

Indexed keywords

ALCOHOL DERIVATIVE; ANTINEOPLASTIC AGENT; ESTERASE; OXIDOREDUCTASE; PHASEOLINONE; PHASEOLINONE ESTER; PHENOL DERIVATIVE; PHOMENONE; PHOMENONE ESTER; PREUSSOMERIN G; PREUSSOMERIN G ESTER; PREUSSOMERIN I; PREUSSOMERIN I ESTER; PROPIONIC ACID DERIVATIVE; QUINONEPROPIONIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN KB; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; FUNGUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IC 50; NONHUMAN; VERO CELL;

CELL LINE, TUMOR; ESTERS; FUNGI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION-REDUCTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, INFRARED;

EID: 34249997771     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.930     Document Type: Article

References (23)

1. Seephonkai P., Isaka M., Kittapoop P., Palittapongarnpim P., Kamchonwongpaisan S., Tanticharoen M., Thebtaranonth Y., Planta Med., 68, 45-48 (2002).
2. Isaka M., Jaturapat A., Kladwang W., Punya J., Lertwerawat Y., Tanticharoen M., Thebtaranonth Y., Planta Med., 66, 473-475 (2000).
3. Danson S., Ward T. H., Butler J., Ranson M., Cancer Treat. Rev., 30, 437-449 (2004).
4. Brown J. M., Giaccia A. J., Cancer Res., 58, 1408-1416 (1998).
5. Gharat L., Visser P., Brummelhuis M., Guiles R., Chikhale P. J., Med. Chem. Res., 8, 444-456 (1998).
6. Weerapreeyakul N., Visser P., Brummelhuis M., Gharat L., Chikhale P. J., Med. Chem. Res., 10, 149-163 (2000).
7. Nicolaou M. G., Yuan C. S., Borchardt R. T., J. Org. Chem., 61, 8636-8641 (1996).
8. Carpino L. A., Triolo S. A., Berglund R. A., J. Org. Chem., 54, 3303-3310 (1989).
9. Amsberry K. L., Borchardt R. T., Pharm. Res., 8, 323-330 (1991).
10. Bruice T. C., Marquardt F., Org. Biol. Chem., 84, 365-370 (1962).
11. Cain B. F., J. Org. Chem., 41, 2029-2031 (1976).
12. Caswell M., Schmir G. L., J. Am. Chem. Soc., 102, 4815-4821 (1980).
13. Ueda Y., Mikkilineni A. B., Knipe J. O., Rose W. C., Casazza A. M., Vyas D. M., Bioorg. Med. Chem. Lett., 3, 1761-1766 (1993).
14. Chikhale P. J., Nakagami H., Borchardt R. T., Pharm. Res., 12, S-245 (1995).
15. Shan D., Nicolaou M. G., Borchardt R. T., Wang G., J. Pharm. Sci., 86, 765-767 (1997).
16. Pauletti G. M., Gangwar S., Wang B., Borchardt R. T., Pharm. Res., 14, 11-17 (1997).
17. Wang B., Nimkar K., Wang W., Zhang H., Shan D., Gudmundsson O., Gangwar S., Siahaan T., Borchardt R. T., J. Peptide Res., 53, 370-382 (1999).
18. Greenwald R. B., Choe Y. H., Conover C. D., Shum K., Wu D., Royzen M., J. Med. Chem., 43, 475-487 (2000).
19. Huang S.-T., Lin Y.-L., Org. Lett., 8, 265-268 (2006).
20. Ross D., Beall H., Traver D., Siegel D., Philips R. M., Gibson N. W., Oncol. Res., 6, 493-500 (1994).
21. Godage H. Y., Chamber D. J., Evans G. R., Fairbanks A. J., Org. Biomol. Chem., 1, 3772-3786 (2003).
22. Mosmann T., J. Immunol. Methods, 6, 55-63 (1983).
23. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesh H., Kenney S., Boyd M. R., J. Natl. Cancer Inst., 82, 1107-1112 (1990).